Focused Ultrasound for Opioid Use Disorder (LIFU Trial)

N/A

Recruiting

Led By Mary R Lee, MD

Research Sponsored by Washington D.C. Veterans Affairs Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current diagnosis of Chronic Back Pain with pain duration of at least three months, with back pain being an ongoing problem for at least half the days of the last six months

Be in treatment for OUD including buprenorphine or methadone

Must not have

Evidence of neuropathic pain

Current DSM-5 diagnosis of schizophrenia or schizo-affective disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately prior to 1 session low-intensity focused ultrasound (lifu) and within 1 hour post lifu; immediately prior to 1 session sham and with in 1 hour post sham

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to use low intensity focused ultrasound to block a specific part of the brain to see how it affects pain, anxiety, and cravings in people with opioid use disorder, anxiety, and chronic back

Who is the study for?

This trial is for individuals with chronic back pain, anxiety, and opioid use disorder. Participants must undergo MRI and neurological assessments to ensure safety. Details on specific inclusion or exclusion criteria are not provided.

What is being tested?

The study tests if low intensity focused ultrasound (LIFU) can safely target the anterior insula to affect pain, anxiety, and opioid cravings compared to a sham (fake) treatment.

What are the potential side effects?

Potential side effects are not detailed but will be monitored through clinical assessments and patient feedback regarding the tolerability of LIFU versus sham stimulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had chronic back pain for at least 3 months, with pain on most days in the last 6 months.

Select...

I am currently receiving treatment for opioid use disorder with buprenorphine or methadone.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I experience nerve pain.

Select...

I have been diagnosed with schizophrenia or schizo-affective disorder.

Select...

I have a history of seizures or neurological disorders.

Select...

I have had cancer spread, significant weight loss, inflammation disorders, or cauda equina syndrome.

Select...

I use benzodiazepines or opiates daily, but not buprenorphine or methadone.

Select...

I do not have any unstable health conditions like heart failure or severe infections.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately prior to 1 session low-intensity focused ultrasound (lifu) and within 1 hour post lifu; immediately prior to 1 session sham and with in 1 hour post sham

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately prior to 1 session low-intensity focused ultrasound (lifu) and within 1 hour post lifu; immediately prior to 1 session sham and with in 1 hour post sham

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately prior to 1 session low-intensity focused ultrasound (lifu) and within 1 hour post lifu; immediately prior to 1 session sham and with in 1 hour post sham for reporting.